Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis

被引:2
|
作者
Kuykendall, Andrew T. [1 ]
Talati, Chetasi [1 ]
Padron, Eric [1 ]
Sweet, Kendra [1 ]
Lancet, Jeffrey E. [1 ]
List, Alan F. [1 ]
Sallman, David [1 ]
Komrokji, Rami S. [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
关键词
SURVIVAL; JAK2; CALR; MPL;
D O I
10.1002/ajh.25625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E314 / E317
页数:4
相关论文
共 50 条
  • [1] Mutation Landscape and Prognostic Correlates of ASXL1 Variants in Primary and Secondary Myelofibrosis
    Coltro, Giacomo
    Guglielmelli, Paola
    Rotunno, Giada
    Mannarelli, Carmela
    Maccari, Chiara
    Salvadori, Costanza
    Vanderwert, Fiorenza Irushani
    Mannelli, Francesco
    Salvati, Cristina
    Vannucchi, Alessandro
    BLOOD, 2021, 138
  • [2] Calmodulin Kinase II is a Mutation-Specific Driver of Disease in Hypertrophic Cardiomyopathy
    Hauck, Garrett
    Vasquez, Catherine
    Lynn, Melissa
    Klass, Matthew
    Langlais, Paul
    Hamilton, Shanna
    Tardiff, Jil
    CIRCULATION RESEARCH, 2024, 135
  • [3] Pruritus in primary myelofibrosis: Clinical and laboratory correlates
    Vaa, Brianna E.
    Wolanskyj, Alexandra P.
    Roeker, Lindsey
    Pardanani, Animesh
    Lasho, Terra L.
    Finke, Christy M.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 136 - 138
  • [4] Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes
    Xiaobao Dong
    Dandan Huang
    Xianfu Yi
    Shijie Zhang
    Zhao Wang
    Bin Yan
    Pak Chung Sham
    Kexin Chen
    Mulin Jun Li
    Communications Biology, 3
  • [5] Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes
    Dong, Xiaobao
    Huang, Dandan
    Yi, Xianfu
    Zhang, Shijie
    Wang, Zhao
    Yan, Bin
    Sham, Pak Chung
    Chen, Kexin
    Li, Mulin Jun
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [6] SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates
    Loscocco, Giuseppe G.
    Guglielmelli, Paola
    Mannelli, Francesco
    Mora, Barbara
    Mannarelli, Carmela
    Rotunno, Giada
    Pancani, Fabiana
    Maccari, Chiara
    Bartalucci, Niccolo
    Romagnoli, Simone
    Coltro, Giacomo
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (09) : E347 - E349
  • [7] Nonsense mutation dystrophinopathy: How mutation-specific treatments changed our clinical practice?
    Ardicli, D.
    Konuskan, B.
    Haliloglu, G.
    Alikasifoglu, M.
    Topaloglu, H.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S253 - S253
  • [8] The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
    Genovese, Elena
    Mirabile, Margherita
    Rontauroli, Sebastiano
    Sartini, Stefano
    Fantini, Sebastian
    Tavernari, Lara
    Maccaferri, Monica
    Guglielmelli, Paola
    Bianchi, Elisa
    Parenti, Sandra
    Carretta, Chiara
    Mallia, Selene
    Castellano, Sara
    Colasante, Corrado
    Balliu, Manjola
    Bartalucci, Niccolo
    Palmieri, Raffaele
    Ottone, Tiziana
    Mora, Barbara
    Potenza, Leonardo
    Passamonti, Francesco
    Voso, Maria Teresa
    Luppi, Mario
    Vannucchi, Alessandro Maria
    Tagliafico, Enrico
    Manfredini, Rossella
    ANTIOXIDANTS, 2022, 11 (01)
  • [9] Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review
    Alshemmari, Salem H.
    Rajan, Reshmi
    Emadi, Ashkan
    MEDICAL PRINCIPLES AND PRACTICE, 2016, 25 (06) : 501 - 509
  • [10] Comparison of Next-Generation Sequencing and Mutation-Specific Platforms in Clinical Practice
    Hinrichs, John W. J.
    Van Blokland, W. T. Marja
    Moons, Michiel J.
    Radersma, Remco D.
    Radersma-Van Loon, Joyce H.
    de Voijs, Carmen M. A.
    Rappel, Sophie B.
    Koudijs, Marco J.
    Besselink, Nicolle J. M.
    Willems, Stefan M.
    de Weger, Roel A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (04) : 573 - 578